CanAm Scientific, a global leader in technology, supply and manufacturing, has signed an exclusive agreement with Clemenceau Medical Center Hospital in Dubai to establish the hospital as the first medical institution in the United Arab Emirates to offer minimally invasive HIFU treatment for prostate diseases.

Through their partnership, CanAm Scientific will supply, maintain and provide training on the Sonoblate HIFU system. This state-of-the-art equipment uses focused ultrasound waves to treat a variety of illness, including prostate cancer.

Aird & Berlis represented CanAm Scientific in this matter with a team including Peter A. Dalglish, Jesse Rosensweet and Jessie Lewis.